Home News Current Movement: Omnicell (NASDAQ: OMCL)

Current Movement: Omnicell (NASDAQ: OMCL)


Omnicell is part of the technology sector and is in the application software industry. The company CEO is Randall A. Lipps. Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.

Previous Intraday Trading Performance:

The OMCL stock showed a previous change of -1.26% with an open at 84.00 and a close of 82.39. It reached an intraday high of 84.05 and a low of 81.56.

SeekingAlpha:  Bulletproof Investing Performance Update: Week 78


The stock has a market cap of $3.4b with 41.2m shares outstanding, of which the float is 40.2m shares. Trading volume reached 188,666 shares compared to its average volume of 231,858 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Omnicell shares returned 2.58% and in the past 30 trading days it returned 0.65%. Over three months, it changed -1.89%. In one year it has changed 63.31% and within that year its 52-week high was 86.87 and its 52-week low was 49.45. OMCL stock is 66.61% above its 52 Week Low.

Our calculations show a 200 day moving average of 73.38 and a 50 day moving average of 80.24. Currently OMCL stock is trading 12.28% above its 200 day moving average.

SeekingAlpha:  Bulletproof Investing Performance Update: Week 78


The last annual fiscal EPS for the company was reported at 0.92 that ended on 31st of December 2018, which according to the previous close, that is a PE of 89.55. Based on 4 analyst estimates, the consensus EPS for the next quarter is 0.23. The TTM EPS is 1.50, which comes to a TTM PE of 54.93. Historically, the PE high was 2,770.00 and the PE low was 29.80. If the stock reached its PE low, that would represent a price of 44.70, which is a decrease of -45.75%.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 04/25/2019): 0.08
4thQtr of 2018 (Reported on 02/07/2019): 0.36
3rdQtr of 2018 (Reported on 10/25/2018): 0.33
2ndQtr of 2018 (Reported on 07/26/2018): 0.16
1stQtr of 2018 (Reported on 04/26/2018): 0.07

Base on our calculations, the intrinsic value per share is 53.97, which means it may be overvalued by -52.67%.

Indicators to Watch:

The current calculated beta is 1.11.

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 6.11%, return on assets is 3.60%, profit margin is 4.76%, price-to-sales is 4.26 and price-to-book is 4.71.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 2  :Past Performance Score
 5  :Financial Strength Score
 4  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.